Nitric oxide induces cell death in canine cruciate ligament cells by activation of tyrosine kinase and reactive oxygen species

BMC Veterinary Research

David Spreng²  Andreas Zurbriggen¹  Simone Forterre² 

[1] Division of Clinical Research, Department of Clinical Research and Veterinary Public Health, University of Bern, Bremgartenstrasse 109,, 3012, Bern, Switzerland;Division of Small Animal Surgery and Orthopedics, Vetsuisse Faculty Bern, Department of Clinical Veterinary Medicine, University of Bern, Länggassstrasse 128,, 3012, Bern, Switzerland

关键词: Tyrosine kinase;    Reactive oxygen species;    Sodium nitroprusside;    Nitric oxide;    Apoptosis;    Dogs;    Cranial cruciate ligament rupture;   

Others  :  1119847
DOI  :  10.1186/1746-6148-8-40

 received in 2012-01-12, accepted in 2012-03-22,  发布年份 2012

【 摘 要 】

Background

There is increasing evidence suggesting that development of progressive canine cranial cruciate ligament (CCL) rupture involves a gradual degeneration of the CCL itself, initiated by a combination of factors, ranging from mechanical to biochemical. To date, knowledge is lacking to what extent cruciate disease results from abnormal biomechanics on a normal ligament or contrary how far preliminary alterations of the ligament due to biochemical factors provoke abnormal biomechanics. This study is focused on nitric oxide (NO), one of the potential biochemical factors. The NO-donor sodium nitroprusside (SNP) has been used to study NO-dependent cell death in canine cranial and caudal cruciate ligament cells and to characterize signaling mechanisms during NO-stimulation.

Results

Sodium nitroprusside increased apoptotic cell death dose- and time-dependently in cruciate ligamentocytes. Cells from the CCL were more susceptible to apoptosis than CaCL cells. Caspase-3 processing in response to SNP was not detected. Testing major upstream and signal transducing pathways, NO-induced cruciate ligament cell death seemed to be mediated on different levels. Specific inhibition of tyrosine kinase significantly decreased SNP-induced cell death. Mitogen activated protein kinase ERK1 and 2 are activated upon NO and provide anti-apoptotic signals whereas p38 kinase and protein kinase C are not involved. Moreover, data showed that the inhibition reactive oxygen species (ROS) significantly reduced the level of cruciate ligament cell death.

Conclusions

Our data support the hypothesis that canine cruciate ligamentocytes, independently from their origin (CCL or CaCL) follow crucial signaling pathways involved in NO-induced cell death. However, the difference on susceptibility upon NO-mediated apoptosis seems to be dependent on other pathways than on these tested in the present study. In both, CCL and CaCL, the activation of the tyrosine kinase and the generation of ROS reveal important signaling pathways. In perspective, new efforts to prevent the development and progression of cruciate disease may include strategies aimed at reducing ROS.

【 授权许可】

   
2012 Forterre et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Bennett D, Tennant B, Lewis DG, Baughan J, May C, Carter S: A reappraisal of anterior cruciate ligament disease in the dog. J Small Anim Pract 1988, 29(5):275-297.
• [2]Comerford EJ, Tarlton JF, Avery NC, Bailey AJ, Innes JF: Distal femoral intercondylar notch dimensions and their relationship to composition and metabolism of the canine anterior cruciate ligament. Osteoarthritis Cartilage 2006, 14(3):273-278.
• [3]Duerr FM, Duncan CG, Savicky RS, Park RD, Egger EL, Palmer RH: Risk factors for excessive tibial plateau angle in large-breed dogs with cranial cruciate ligament disease. J Am Vet Med Assoc 2007, 231(11):1688-1691.
• [4]Guerrero TG, Geyer H, Hassig M, Montavon PM: Effect of conformation of the distal portion of the femur and proximal portion of the tibia on the pathogenesis of cranial cruciate ligament disease in dogs. Am J Vet Res 2007, 68(12):1332-1337.
• [5]Comerford EJ, Smith K, Hayashi K: Update on the aetiopathogenesis of canine cranial cruciate ligament disease. Vet Comp Orthop Traumatol 2011, 24(2):91-98.
• [6]Comerford EJ, Innes JF, Tarlton JF, Bailey AJ: Investigation of the composition, turnover, and thermal properties of ruptured cranial cruciate ligaments of dogs. Am J Vet Res 2004, 65(8):1136-1141.
• [7]Doom M, de Bruin T, de Rooster H, van Bree H, Cox E: Immunopathological mechanisms in dogs with rupture of the cranial cruciate ligament. Vet Immunol Immunopathol 2008, 125(1–2):143-161.
• [8]Hayashi K, Manley PA, Muir P: Cranial cruciate ligament pathophysiology in dogs with cruciate disease: a review. J Am Anim Hosp Assoc 2004, 40(5):385-390.
• [9]Spreng D, Sigrist N, Jungi T, Busato A, Lang J, Pfister H, Schawalder P: Nitric oxide metabolite production in the cranial cruciate ligament, synovial membrane, and articular cartilage of dogs with cranial cruciate ligament rupture. Am J Vet Res 2000, 61(5):530-536.
• [10]Gyger O, Botteron C, Doherr M, Zurbriggen A, Schawalder P, Spreng D: Detection and distribution of apoptotic cell death in normal and diseased canine cranial cruciate ligaments. Vet J 2007, 174(2):371-377.
• [11]Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996, 271(5 Pt 1):C1424-C1437.
• [12]Nishida K, Doi T, Matsuo M, Ishiwari Y, Tsujigiwa H, Yoshida A, Shibahara M, Inoue H: Involvement of nitric oxide in chondrocyte cell death in chondro-osteophyte formation. Osteoarthritis Cartilage 2001, 9(3):232-237.
• [13]Kuhn K, Lotz M: Mechanisms of sodium nitroprusside-induced death in human chondrocytes. Rheumatol Int 2003, 23(5):241-247.
• [14]Hashimoto H, Tanaka M, Suda T, Tomita T, Hayashida K, Takeuchi E, Kaneko M, Takano H, Nagata S, Ochi T: Soluble Fas ligand in the joints of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum 1998, 41(4):657-662.
• [15]Hashimoto S, Takahashi K, Amiel D, Coutts RD, Lotz M: Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis. Arthritis Rheum 1998, 41(7):1266-1274.
• [16]Pelletier JP, Jovanovic DV, Lascau-Coman V, Fernandes JC, Manning PT, Connor JR, Currie MG, Martel-Pelletier J: Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo: possible link with the reduction in chondrocyte apoptosis and caspase 3 level. Arthritis Rheum 2000, 43(6):1290-1299.
• [17]Pelletier JP, Lascau-Coman V, Jovanovic D, Fernandes JC, Manning P, Connor JR, Currie MG, Martel-Pelletier J: Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors. J Rheumatol 1999, 26(9):2002-2014.
• [18]Blanco FJ, Ochs RL, Schwarz H, Lotz M: Chondrocyte apoptosis induced by nitric oxide. Am J Pathol 1995, 146(1):75-85.
• [19]Notoya K, Jovanovic DV, Reboul P, Martel-Pelletier J, Mineau F, Pelletier JP: The induction of cell death in human osteoarthritis chondrocytes by nitric oxide is related to the production of prostaglandin E2 via the induction of cyclooxygenase-2. J Immunol 2000, 165(6):3402-3410.
• [20]Kim SJ, Ju JW, Oh CD, Yoon YM, Song WK, Kim JH, Yoo YJ, Bang OS, Kang SS, Chun JS: ERK-1/2 and p38 kinase oppositely regulate nitric oxide-induced apoptosis of chondrocytes in association with p53, caspase-3, and differentiation status. J Biol Chem 2002, 277(2):1332-1339.
• [21]Jovanovic DV, Mineau F, Notoya K, Reboul P, Martel-Pelletier J, Pelletier JP: Nitric oxide induced cell death in human osteoarthritic synoviocytes is mediated by tyrosine kinase activation and hydrogen peroxide and/or superoxide formation. J Rheumatol 2002, 29(10):2165-2175.
• [22]Louis E, Remer KA, Doherr MG, Neumann U, Jungi T, Schawalder P, Spreng D: Nitric oxide and metalloproteinases in canine articular ligaments: a comparison between the cranial cruciate, the medial genual collateral and the femoral head ligament. Vet J 2006, 172(3):466-472.
• [23]Riitano MC, Pfister H, Engelhardt P, Neumann U, Reist M, Zurbriggen A, Stoffel M, Peel J, Jungi T, Schawalder P, et al.: Effects of stimulus with proinflammatory mediators on nitric oxide production and matrix metalloproteinase activity in explants of cranial cruciate ligaments obtained from dogs. Am J Vet Res 2002, 63(10):1423-1428.
• [24]Forterre S, Zurbriggen A, Spreng D: In vitro effect of different mediators of apoptosis on canine cranial and caudal cruciate ligament fibroblasts and its reversibility by pancaspase inhibitor zVAD.fmk. Vet Immunol Immunopathol 2011, 139:264-270.
• [25]Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C: A novel assay for apoptosis. J Immunol Methods 1995, 184(1):39-51.
• [26]Peter ME: Programmed cell death: Apoptosis meets necrosis. Nature 2011, 471(7338):310-312.
• [27]Adams JM, Cory S: The Bcl-2 protein family: arbiters of cell survival. Science 1998, 281(5381):1322-1326.
• [28]Borner C, Monney L: Apoptosis without caspases: an inefficient molecular guillotine? Cell Death Differ 1999, 6(6):497-507.
• [29]Lorenzo HK, Susin SA, Penninger J, Kroemer G: Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death. Cell Death Differ 1999, 6(6):516-524.
• [30]Chipuk JE, Green DR: Do inducers of apoptosis trigger caspase-independent cell death? Nat Rev Mol Cell Biol 2005, 6(3):268-275.
• [31]Cano E, Mahadevan LC: Parallel signal processing among mammalian MAPKs. Trends Biochem Sci 1995, 20(3):117-122.
• [32]Shakibaei M, Schulze-Tanzil G, de Souza P, John T, Rahmanzadeh M, Rahmanzadeh R, Merker HJ: Inhibition of mitogen-activated protein kinase kinase induces apoptosis of human chondrocytes. J Biol Chem 2001, 276(16):13289-13294.
• [33]Callsen D, Brune B: Role of mitogen-activated protein kinases in S-nitrosoglutathione-induced macrophage apoptosis. Biochemistry 1999, 38(8):2279-2286.
• [34]Pelletier JP, Fernandes JC, Jovanovic DV, Reboul P, Martel-Pelletier J: Chondrocyte death in experimental osteoarthritis is mediated by MEK 1/2 and p38 pathways: role of cyclooxygenase-2 and inducible nitric oxide synthase. J Rheumatol 2001, 28(11):2509-2519.
• [35]Wajant H, Pfizenmaier K, Scheurich P: Tumor necrosis factor signaling. Cell Death Differ 2003, 10(1):45-65.
• [36]Chong YP, Ia KK, Mulhern TD, Cheng HC: Endogenous and synthetic inhibitors of the Src-family protein tyrosine kinases. Biochim Biophys Acta 2005, 1754(1–2):210-220.
• [37]Kobayashi S, Nishimura J, Kanaide H: Cytosolic Ca2+ transients are not required for platelet-derived growth factor to induce cell cycle progression of vascular smooth muscle cells in primary culture. Actions of tyrosine kinase. J Biol Chem 1994, 269(12):9011-9018.
• [38]Wei H, Bowen R, Cai Q, Barnes S, Wang Y: Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proceedings of the Society for Experimental Biology and Medicine Society for Experimental Biology and Medicine 1995, 208(1):124-130.
• [39]Hofer D, Forterre S, Schweighauser A, Krayer M, Doherr M, Schawalder P, Zurbriggen A, Spreng D: Selective iNOS-inhibition does not influence apoptosis in ruptured canine cranial cruciate ligaments. Vet Comp Orthop Traumatol 2009, 22(3):198-203.
• [40]Henrotin YE, Bruckner P, Pujol JP: The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthritis Cartilage 2003, 11(10):747-755.
• [41]Yudoh K, Nguyen T, Nakamura H, Hongo-Masuko K, Kato T, Nishioka K: Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: oxidative stress induces chondrocyte telomere instability and downregulation of chondrocyte function. Arthritis Res Ther 2005, 7(2):R380-R391. BioMed Central Full Text
• [42]Del Carlo M Jr, Loeser RF: Nitric oxide-mediated chondrocyte cell death requires the generation of additional reactive oxygen species. Arthritis Rheum 2002, 46(2):394-403.
• [43]Kuhn K, Shikhman AR, Lotz M: Role of nitric oxide, reactive oxygen species, and p38 MAP kinase in the regulation of human chondrocyte apoptosis. J Cell Physiol 2003, 197(3):379-387.
• [44]Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needleman P: Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 1993, 90(15):7240-7244.
• [45]Salvemini D: Regulation of cyclooxygenase enzymes by nitric oxide. Cell Mol Life Sci 1997, 53(7):576-582.